Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • C07K14/475—Growth factors; Growth regulators
  • C07K14/50—Fibroblast growth factor [FGF]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides
  • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • A61K38/18—Growth factors; Growth regulators
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
  • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
  • A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
  • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
  • A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P5/00—Drugs for disorders of the endocrine system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Organic Chemistry (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Veterinary Medicine (AREA)
• Pharmacology & Pharmacy (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Molecular Biology (AREA)
• Genetics & Genomics (AREA)
• Zoology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Toxicology (AREA)
• General Chemical & Material Sciences (AREA)
• Epidemiology (AREA)
• Biophysics (AREA)
• Gastroenterology & Hepatology (AREA)
• Biochemistry (AREA)
• Biomedical Technology (AREA)
• Biotechnology (AREA)
• Wood Science & Technology (AREA)
• General Engineering & Computer Science (AREA)
• Dermatology (AREA)
• Physics & Mathematics (AREA)
• Plant Pathology (AREA)
• Diabetes (AREA)
• Endocrinology (AREA)
• Immunology (AREA)
• Microbiology (AREA)
• Peptides Or Proteins (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Saccharide Compounds (AREA)

Applications Claiming Priority (2)

Publications (2)

Family

ID=22198501

Family Applications (1)

Country Status (25)

Families Citing this family (42)

Family Cites Families (7)

• 1994
  • 1994-04-28 EP EP04023638A patent/EP1493812A3/en not_active Ceased
  • 1994-04-28 PT PT94916597T patent/PT706563E/pt unknown
  • 1994-04-28 JP JP50346495A patent/JP3570516B2/ja not_active Expired - Fee Related
  • 1994-04-28 SK SK1532-95A patent/SK153295A3/sk unknown
  • 1994-04-28 NZ NZ266622A patent/NZ266622A/en unknown
  • 1994-04-28 DK DK94916597T patent/DK0706563T3/da active
  • 1994-04-28 KR KR1019950705997A patent/KR960703433A/ko not_active Ceased
  • 1994-04-28 BR BR9407035A patent/BR9407035A/pt not_active Application Discontinuation
  • 1994-04-28 ES ES94916597T patent/ES2227527T3/es not_active Expired - Lifetime
  • 1994-04-28 WO PCT/US1994/004694 patent/WO1995001434A1/en not_active Ceased
  • 1994-04-28 AU AU68208/94A patent/AU681405B2/en not_active Ceased
  • 1994-04-28 EP EP94916597A patent/EP0706563B1/en not_active Expired - Lifetime
  • 1994-04-28 PL PL94312257A patent/PL312257A1/xx unknown
  • 1994-04-28 AT AT94916597T patent/ATE278777T1/de active
  • 1994-04-28 HU HU9503857A patent/HUT73453A/hu unknown
  • 1994-04-28 DE DE1994634053 patent/DE122006000005I2/de active Active
  • 1994-04-28 CZ CZ953437A patent/CZ343795A3/cs unknown
  • 1994-04-28 CN CN94193193A patent/CN1129955A/zh active Pending
  • 1994-04-28 CA CA002166278A patent/CA2166278A1/en not_active Abandoned
  • 1994-04-28 DE DE69434053T patent/DE69434053T2/de not_active Expired - Lifetime
• 1995
  • 1995-03-27 US US08/410,941 patent/US5677278A/en not_active Expired - Lifetime
  • 1995-06-06 US US08/467,937 patent/US5863767A/en not_active Expired - Lifetime
  • 1995-06-06 US US08/468,546 patent/US5773586A/en not_active Expired - Lifetime
  • 1995-06-06 US US08/468,547 patent/US5843883A/en not_active Expired - Lifetime
  • 1995-12-20 BG BG100236A patent/BG100236A/xx unknown
  • 1995-12-20 NO NO955189A patent/NO955189D0/no unknown
  • 1995-12-22 FI FI956203A patent/FI956203A7/fi unknown
• 1998
  • 1998-05-08 US US09/074,950 patent/US6074848A/en not_active Expired - Lifetime
• 2000
  • 2000-05-16 US US09/573,068 patent/US6677301B1/en not_active Expired - Fee Related
• 2004
  • 2004-02-10 JP JP2004034289A patent/JP2004166709A/ja not_active Withdrawn
• 2005
  • 2005-11-17 JP JP2005333438A patent/JP2006075173A/ja not_active Withdrawn
• 2006
  • 2006-01-26 NL NL300217C patent/NL300217I2/nl unknown
  • 2006-01-27 LU LU91215C patent/LU91215I2/en unknown
  • 2006-01-31 FR FR06C0004C patent/FR06C0004I2/fr active Active
• 2007
  • 2007-06-11 US US11/811,560 patent/US20090093400A1/en not_active Abandoned
• 2008
  • 2008-11-26 JP JP2008301630A patent/JP4662569B2/ja not_active Expired - Lifetime

Also Published As

Similar Documents